EUVIMEDEUVIMED entdecken
Crossref

Improving Chemotherapy Effectiveness: Utilizing CuS Nanoparticles Coated with AS1411 Aptamer and Chitosan for Targeted Delivery of Doxorubicin to Cancerous Cells

Maryam Imanimoghadam, Elnaz Yaghoobi, Fatemeh Alizadeh, Mohammad Ramezani, Mona Alibolandi, Khalil Abnous, Seyed Mohammad Taghdisi

Journal of Pharmaceutical Sciences · 2024

DOI: 10.1016/j.xphs.2024.02.005 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Pharmaceutical Sciences, 2024. Verfasst von Maryam Imanimoghadam und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran. Hauptthemen laut MEDLINE: Doxorubicin, Chitosan, Aptamers, Nucleotide, Nanoparticles. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 49 Literaturangaben. Gefördert von: Mashhad University of Medical Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Here, a novel targeted nanostructure complex was designed as an alternative to the traditional treatment approaches for breast cancer. A delivery system utilizing CuS nanoparticles (CuS NPs) was developed for the purpose of targeted administration of doxorubicin (Dox), an anticancer agent. To regulate Dox release, chitosan (CS), a biodegradable and hydrophilic polymer with biocompatible properties, was applied to coat the Dox-loaded CuS NPs. Furthermore, AS1411 aptamer, served as a targeting agent for breast cancer cells (MCF-7 and 4T1 cells), was conjugated with CS-Dox-CuS NPs effectively. To assess the effectiveness of APT-CS-CuS NPs, various methods such as flow cytometry analysis, MTT assay, fluorescence imaging, and in vivo antitumor efficacy were employed. The hollow core and porous surface of CuS NPs improved the Dox loading capacity and entrapment efficiency (almost 100%). The rate of drug release at the tumor site (citrate buffer with pH 5.6) exhibited a marked increase in comparison to that observed within the physiological environment (phosphate buffer with pH 7.4). The targeted formulation (APT-CS-Dox-CuS NPs) significantly increased cytotoxicity of the Dox payload in target cells, including 4T1 (p ≤ 0.0001 (****)) and MCF7 (p ≤ 0.01 (**)) cells compared to CHO cells. Moreover, the ability of tumor growth inhibition of the targeted system was significantly (p ≤ 0.05 (*)) more than free Dox in tumor-bearing mice. The findings indicate that the targeted formulation augmented effectiveness and specificity while minimizing harm to non-targeted cells, signifying its potential as a sophisticated cancer drug delivery system.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DoxorubicinChitosanAptamers, NucleotideNanoparticlesAnimalsHumansFemaleMiceMCF-7 CellsCell Line, TumorAntibiotics, AntineoplasticBreast NeoplasmsDrug Delivery SystemsMice, Inbred BALB CDrug LiberationDrug CarriersCricetulusCHO CellsCopperOligodeoxyribonucleotides

Stichwörter der Autor:innen

AS1411 aptamerCancer treatmentCuS nanoparticleDoxorubicinTargeted drug delivery

Substanzen

DoxorubicinChitosanAptamers, NucleotideAGRO 100Antibiotics, AntineoplasticDrug Carrierscupric sulfideCopperOligodeoxyribonucleotides

Autor:innen und Institutionen

  • School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Pharmaceutical Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran; Department of Chemistry and Biomolecular Sciences, University of Ottawa, 10 Marie-Curie, Ottawa…
  • Pharmaceutical Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Pharmaceutical Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran; Department of Medicinal Chemistry, School of Pharmacy, Mashhad University of Medical Sciences,…
  • Targeted Drug Delivery Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran; Department of Pharmaceutical Biotechnology, School of Pharmacy, Mashhad University of M…

Förderung

  • Mashhad University of Medical Sciences

Zitieren

APA

Imanimoghadam, M., Yaghoobi, E., Alizadeh, F., Ramezani, M., Alibolandi, M., Abnous, K., & Taghdisi, S. M. (2024). Improving Chemotherapy Effectiveness: Utilizing CuS Nanoparticles Coated with AS1411 Aptamer and Chitosan for Targeted Delivery of Doxorubicin to Cancerous Cells. Journal of Pharmaceutical Sciences. https://doi.org/10.1016/j.xphs.2024.02.005

Vancouver

Imanimoghadam M, Yaghoobi E, Alizadeh F, Ramezani M, Alibolandi M, Abnous K, et al. Improving Chemotherapy Effectiveness: Utilizing CuS Nanoparticles Coated with AS1411 Aptamer and Chitosan for Targeted Delivery of Doxorubicin to Cancerous Cells. Journal of Pharmaceutical Sciences. 2024. doi:10.1016/j.xphs.2024.02.005

BibTeX
@article{Imanimoghadam2024,
  author = {Imanimoghadam, Maryam and Yaghoobi, Elnaz and Alizadeh, Fatemeh and Ramezani, Mohammad and Alibolandi, Mona and Abnous, Khalil and Taghdisi, Seyed Mohammad},
  title = {Improving Chemotherapy Effectiveness: Utilizing CuS Nanoparticles Coated with AS1411 Aptamer and Chitosan for Targeted Delivery of Doxorubicin to Cancerous Cells},
  journal = {Journal of Pharmaceutical Sciences},
  year = {2024},
  doi = {10.1016/j.xphs.2024.02.005}
}
Kostenlos starten →